MDEA

MDEA is a Schedule I controlled substance in most countries. The substance is characterized by a more sedating, 'stoning' quality compared to MDMA, with less emphasis on social connection and more on physical relaxation. MDEA requires careful dosing with an accurate milligram scale, adequate hydration without over-drinking, and temperature regulation in warm environments. Users with personal or family histories of heart conditions or mental health disorders should avoid use.

Also known as: Mde, Eve

Classification

Chemical: Amphetamine
Chemical: Phenethylamine
Psychoactive: Entactogen
Psychoactive: Psychedelic
Psychoactive: Stimulant
Tag: Empathogen
Tag: MDxx
Tag: Research-Chemical
Tag: Substituted amphetamine
Tag: Tentative

Effects

Physical Euphoria
Spontaneous Bodily Sensations
Sedation
Teeth Grinding
Pupil Dilation
Temperature Regulation Suppression
Cognitive Euphoria
Empathy Affection And Sociability Enhancement
Anxiety Suppression
Time Distortion
Talkativeness
Alertness Enhancement
Perception Of Bodily Heaviness
Tactile Enhancement
Increased Music Appreciation
Light Sensitivity
Open Eye Visuals
Vibrating Vision

Routes of Administration

Oral

Dosage

Threshold: 40 mg
Light: 70-120 mg
Common: 120-180 mg
Strong: 150-200 mg
Heavy: 225 mg

Duration

Onset: 0.3-1 h
Comeup: 0.2-0.5 h
Peak: 1.5-2 h
Offset: 1-2 h
After Effects: 12-48 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu